(NASDAQ: CLOV) CLOVER HEALTH INVESTMENTS's forecast annual revenue growth rate of 38.03% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 7.46%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.
CLOVER HEALTH INVESTMENTS's revenue in 2022 is $2,146,050,000.On average, 2 Wall Street analysts forecast CLOV's revenue for 2022 to be $1,602,645,348,479, with the lowest CLOV revenue forecast at $1,575,019,898,039, and the highest CLOV revenue forecast at $1,630,270,798,919. On average, 2 Wall Street analysts forecast CLOV's revenue for 2023 to be $2,079,439,984,460, with the lowest CLOV revenue forecast at $2,071,444,887,511, and the highest CLOV revenue forecast at $2,087,435,081,409.
In 2024, CLOV is forecast to generate $2,717,812,263,574 in revenue, with the lowest revenue forecast at $2,717,812,263,574 and the highest revenue forecast at $2,717,812,263,574.